| Dermatitis |
1 |
1 |
| Arthritis |
0 |
0.99 |
| Psoriatic Arthritis |
0 |
0.57 |
| Atopic Dermatitis |
0 |
0.55 |
| Osteoarthritis |
0 |
0.44 |
| Spondylitis, Spondylosis, Kyphosis |
0 |
0.42 |
| Tenosynovitis |
0 |
0.33 |
| Otolaryngology |
0 |
0.27 |
| Adverse Effects |
0 |
0.23 |
| NHS |
0 |
0.21 |
| Patient Safety |
0 |
0.2 |
| Pain Management |
0 |
0.16 |
| Genetics |
0 |
0.14 |
| Genomic Medicine |
0 |
0.12 |
| Arthralgia |
0 |
0.11 |
| Acute Pain |
0 |
0.1 |
| Cytokines |
0 |
0.09 |
| Epidemiology |
0 |
0.09 |
| Pain |
0 |
0.09 |
| Spine |
0 |
0.09 |
| Biologic Therapy |
0 |
0.08 |
| Psoriasis |
0 |
0.08 |
| Chronic Sinusitis |
0 |
0.07 |
| COX-2 Inhibitor |
0 |
0.07 |
| Cutaneous T-Cell Lymphoma |
0 |
0.07 |
| Eosinophilic Esophagitis |
0 |
0.07 |
| Non-Hodgkin Lymphoma (NHL) |
0 |
0.07 |
| Skin Cancer |
0 |
0.07 |